Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,417 | -16,358 | -14,397 | -12,880 | -11,168 |
| Depreciation Amortization | 78 | 53 | 26 | 147 | 118 |
| Accounts payable and accrued liabilities | -239 | -58 | -50 | 29 | -232 |
| Other Working Capital | -326 | -186 | 365 | 525 | 295 |
| Other Operating Activity | 13,995 | 13,365 | 12,928 | 7,117 | 7,075 |
| Operating Cash Flow | $-4,909 | $-3,184 | $-1,128 | $-5,062 | $-3,912 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,000 | -9,000 | N/A | N/A | N/A |
| PPE Investments | -10 | -2 | N/A | 18 | 16 |
| Other Investing Activity | 0 | 0 | 0 | -2 | -2 |
| Investing Cash Flow | $-9,010 | $-9,002 | $N/A | $16 | $14 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 500 | 500 |
| Debt Repayment | -5 | -5 | -3 | -29 | -26 |
| Common Stock Issued | 15,656 | 15,651 | 15,647 | N/A | N/A |
| Common Stock Repurchased | -12 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 9,199 | 9,199 |
| Financing Cash Flow | $15,639 | $15,646 | $15,644 | $9,670 | $9,673 |
| Beginning Cash Position | 5,127 | 5,127 | 5,127 | 503 | 503 |
| End Cash Position | 6,847 | 8,587 | 19,643 | 5,127 | 6,278 |
| Net Cash Flow | $1,720 | $3,460 | $14,516 | $4,624 | $5,775 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,909 | -3,184 | -1,128 | -5,062 | -3,912 |
| Capital Expenditure | -10 | -2 | N/A | -15 | -9 |
| Free Cash Flow | -4,919 | -3,186 | -1,128 | -5,077 | -3,921 |